Narmafotinib is an orally bioavailable inhibitor of focal adhesion kinase 1 (FAK1), a non-receptor tyrosine kinase overexpressed in various tumor cells. It is used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Narmafotinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Macitentan metabolite M4
pharmaceutical raw material
Tiotropium bromide hydrate
pharmaceutical raw material
Candesartan
pharmaceutical raw material
Methyl candesartan
pharmaceutical raw material
The international HS code for Narmafotinib (CAS 1393653-34-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[2-[2-[2-[2-methoxy-4-(1-methylpiperidin-4-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]ethyl]phenyl]acetamide
AWJVIOYPZZZYAX-UHFFFAOYSA-N
CN1CCC(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)CCC4=CC=CC=C4CC(=O)N)C(F)(F)F)OC
Sourcing Narmafotinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.